1478436

Olopatadyna Związek pokrewny C

United States Pharmacopeia (USP) Reference Standard

• Synonim(y): (11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid, Isoxepac, NSC 300907
• Wzór empiryczny (zapis Hilla): C₁₆H₁₂O₄
• Masa cząsteczkowa: 268.26
• NACRES: NA.24
• UNSPSC Code: 41116107

Właściwości

• grade: pharmaceutical primary standard
• agency: USP
• API family: olopatadine
• manufacturer/tradename: USP
• application(s): pharmaceutical; pharmaceutical (small molecule)
• format: neat
• storage temp.: −20°C

Opis

General description

Find answers to frequently asked questions on USP products in USP FAQs.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Wzorzec referencyjny Olopatadine Related Compound C USP, przeznaczony do stosowania w określonych testach jakości i oznaczeniach, jak określono w kompendiach USP. Również do użytku z monografią USP, taką jak Olopatadine Hydrochloride Ophthalmic Solution.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• Piktogramy: GHS06,GHS08
• Słowo ostrzegawcze: Danger
• Kody zagrożeń: H301,H361,H372
• Hazard Classifications: Acute Tox. 3 Oral - Repr. 2 - STOT RE 1
• Klasa składowania: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• Ostrzeżenia: P202 - P260 - P264 - P280 - P301 + P310 - P405